GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (MIL:1JNJ) » Definitions » E10

Johnson & Johnson (MIL:1JNJ) E10 : €6.94 (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Johnson & Johnson E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Johnson & Johnson's adjusted earnings per share data for the three months ended in Dec. 2024 was €1.347. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €6.94 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Johnson & Johnson's average E10 Growth Rate was 0.40% per year. During the past 3 years, the average E10 Growth Rate was 8.20% per year. During the past 5 years, the average E10 Growth Rate was 9.30% per year. During the past 10 years, the average E10 Growth Rate was 4.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Johnson & Johnson was 16.60% per year. The lowest was -0.10% per year. And the median was 11.45% per year.

As of today (2025-03-24), Johnson & Johnson's current stock price is €151.10. Johnson & Johnson's E10 for the quarter that ended in Dec. 2024 was €6.94. Johnson & Johnson's Shiller PE Ratio of today is 21.77.

During the past 13 years, the highest Shiller PE Ratio of Johnson & Johnson was 33.32. The lowest was 19.28. And the median was 26.39.


Johnson & Johnson E10 Historical Data

The historical data trend for Johnson & Johnson's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson & Johnson E10 Chart

Johnson & Johnson Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 6.53 6.94

Johnson & Johnson Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.53 6.67 6.85 6.44 6.94

Competitive Comparison of Johnson & Johnson's E10

For the Drug Manufacturers - General subindustry, Johnson & Johnson's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Johnson & Johnson's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Johnson & Johnson's Shiller PE Ratio falls into.



Johnson & Johnson E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Johnson & Johnson's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=1.347/133.1571*133.1571
=1.347

Current CPI (Dec. 2024) = 133.1571.

Johnson & Johnson Quarterly Data

per share eps CPI Adj_EPS
201503 1.414 99.621 1.890
201506 1.435 100.684 1.898
201509 1.069 100.392 1.418
201512 1.056 99.792 1.409
201603 1.428 100.470 1.893
201606 1.273 101.688 1.667
201609 1.363 101.861 1.782
201612 1.308 101.863 1.710
201703 1.505 102.862 1.948
201706 1.246 103.349 1.605
201709 1.149 104.136 1.469
201712 -3.372 104.011 -4.317
201803 1.298 105.290 1.642
201806 1.241 106.317 1.554
201809 1.234 106.507 1.543
201812 0.984 105.998 1.236
201903 1.230 107.251 1.527
201906 1.841 108.070 2.268
201909 0.599 108.329 0.736
201912 1.350 108.420 1.658
202003 1.964 108.902 2.401
202006 1.208 108.767 1.479
202009 1.129 109.815 1.369
202012 0.534 109.897 0.647
202103 1.949 111.754 2.322
202106 1.951 114.631 2.266
202109 1.165 115.734 1.340
202112 1.566 117.630 1.773
202203 1.752 121.301 1.923
202206 1.703 125.017 1.814
202209 1.697 125.227 1.804
202212 1.256 125.222 1.336
202303 -0.028 127.348 -0.029
202306 1.809 128.729 1.871
202309 9.567 129.860 9.810
202312 1.531 129.419 1.575
202403 1.233 131.776 1.246
202406 1.793 132.554 1.801
202409 1.000 133.029 1.001
202412 1.347 133.157 1.347

Add all the adjusted EPS together and divide 10 will get our e10.


Johnson & Johnson  (MIL:1JNJ) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Johnson & Johnson's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=151.10/6.94
=21.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Johnson & Johnson was 33.32. The lowest was 19.28. And the median was 26.39.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Johnson & Johnson E10 Related Terms

Thank you for viewing the detailed overview of Johnson & Johnson's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Johnson & Johnson Business Description

Address
One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.

Johnson & Johnson Headlines

No Headlines